However, an interesting study conducted by Liu et al. revealed that down-regulation of HNF-1β by shRNA strategy sensitized ovarian cancer cells to cisplatin- or paclitaxel-induced cytotoxicity both in vitro and in vivo[58]. The gene discussed is HNF1B; the disease is ovarian carcinoma.